Literature DB >> 19745601

Optimization of Streptomyces bacteriophage phi C31 integrase system to prevent post integrative gene silencing in pulmonary type II cells.

Manish Kumar Aneja1, Johannes Geiger, Rabea Imker, Senta Uzgun, Michael Kormann, Guenther Hasenpusch, Christof Maucksch, Carsten Rudolph.   

Abstract

phi C31 integrase has emerged as a potent tool for achieving long-term gene expression in different tissues. The present study aimed at optimizing elements of phi C31 integrase system for alveolar type II cells. Luciferase and beta-galactosidase activities were measured at different time points post transfection. 5-Aza-2'deoxycytidine (AZA) and trichostatin A (TSA) were used to inhibit DNA methyltransferase and histone deacetylase complex (HDAC) respectively. In A549 cells, expression of the integrase using a CMV promoter resulted in highest integrase activity, whereas in MLE12 cells, both CAG and CMV promoter were equally effective. Effect of polyA site was observed only in A549 cells, where replacement of SV40 polyA by bovine growth hormone (BGH) polyA site resulted in an enhancement of integrase activity. Addition of a C-terminal SV40 nuclear localization signal (NLS) did not result in any significant increase in integrase activity. Long-term expression studies with AZA and TSA, provided evidence for post-integrative gene silencing. In MLE12 cells, both DNA methylases and HDACs played a significant role in silencing, whereas in A549 cells, it could be attributed majorly to HDAC activity. Donor plasmids comprising cellular promoters ubiquitin B (UBB), ubiquitin C (UCC) and elongation factor 1 alpha (EF1 alpha) in an improved backbone prevented post-integrative gene silencing. In contrast to A549 and MLE12 cells, no silencing could be observed in human bronchial epithelial cells, BEAS-2B. Donor plasmid coding for murine erythropoietin under the EF1 alpha promoter when combined with phi C31 integrase resulted in higher long-term erythropoietin expression and subsequently higher hematocrit levels in mice after intravenous delivery to the lungs. These results provide evidence for cell specific post integrative gene silencing with C31 integrase and demonstrate the pivotal role of donor plasmid in long-term expression attained with this system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19745601      PMCID: PMC2802687          DOI: 10.3858/emm.2009.41.12.098

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  24 in total

1.  Enhanced efficiency through nuclear localization signal fusion on phage PhiC31-integrase: activity comparison with Cre and FLPe recombinase in mammalian cells.

Authors:  Susanne Andreas; Frieder Schwenk; Birgit Küter-Luks; Nicole Faust; Ralf Kühn
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

2.  High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.

Authors:  N S Yew; M Przybylska; R J Ziegler; D Liu; S H Cheng
Journal:  Mol Ther       Date:  2001-07       Impact factor: 11.454

3.  Site-specific genomic integration produces therapeutic Factor IX levels in mice.

Authors:  Eric C Olivares; Roger P Hollis; Thomas W Chalberg; Leonard Meuse; Mark A Kay; Michele P Calos
Journal:  Nat Biotechnol       Date:  2002-10-15       Impact factor: 54.908

4.  CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo.

Authors:  Nelson S Yew; Hongmei Zhao; Malgorzata Przybylska; I-Huan Wu; Jennifer D Tousignant; Ronald K Scheule; Seng H Cheng
Journal:  Mol Ther       Date:  2002-06       Impact factor: 11.454

5.  Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.

Authors:  D R Gill; S E Smyth; C A Goddard; I A Pringle; C F Higgins; W H Colledge; S C Hyde
Journal:  Gene Ther       Date:  2001-10       Impact factor: 5.250

6.  Stable nonviral genetic correction of inherited human skin disease.

Authors:  Susana Ortiz-Urda; Bhaskar Thyagarajan; Douglas R Keene; Qun Lin; Min Fang; Michele P Calos; Paul A Khavari
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

7.  Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo.

Authors:  Zhi-Ying Chen; Cheng-Yi He; Anja Ehrhardt; Mark A Kay
Journal:  Mol Ther       Date:  2003-09       Impact factor: 11.454

8.  Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.

Authors:  Alberto Auricchio; Erin O'Connor; Daniel Weiner; Guang-Ping Gao; Markus Hildinger; Lili Wang; Roberto Calcedo; James M Wilson
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

9.  Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes.

Authors:  D Goula; N Becker; G F Lemkine; P Normandie; J Rodrigues; S Mantero; G Levi; B A Demeneix
Journal:  Gene Ther       Date:  2000-03       Impact factor: 5.250

10.  High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells.

Authors:  Christopher S Raymond; Philippe Soriano
Journal:  PLoS One       Date:  2007-01-17       Impact factor: 3.240

View more
  3 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

2.  Blastocyst Formation Rate and Transgene Expression are Associated with Gene Insertion into Safe and Non-Safe Harbors in the Cattle Genome.

Authors:  Milad Khorramian Ghahfarokhi; Kianoush Dormiani; Ali Mohammadi; Farnoosh Jafarpour; Mohammad Hossein Nasr-Esfahani
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

3.  Improved site-specific recombinase-based method to produce selectable marker- and vector-backbone-free transgenic cells.

Authors:  Yuan Yu; Qi Tong; Zhongxia Li; Jinhai Tian; Yizhi Wang; Feng Su; Yongsheng Wang; Jun Liu; Yong Zhang
Journal:  Sci Rep       Date:  2014-02-28       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.